The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease

Medicine and Dentistry

• Interstitial Lung Disease 100%
• Idiopathic Pulmonary Fibrosis 80%
• Disease Exacerbation 40%
• Randomized Controlled Trial 20%
• Connective Tissue Disease 20%
• Early Intervention 20%
• Sarcoidosis 20%
• Hypersensitivity Pneumonitis 20%
• Drug Interaction 20%
• Idiopathic Interstitial Pneumonia 20%
• Immunosuppressive Treatment 20%
• Lung 20%
• Diseases 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Interstitial Lung Disease 100%
• Fibrosing Alveolitis 80%
• Disease Exacerbation 40%
• Randomized Controlled Trial 20%
• Immunosuppressive Agent 20%
• Interstitial Pneumonia 20%
• Allergic Pneumonitis 20%
• Drug Interaction 20%
• Connective Tissue Disease 20%
• Diseases 20%